Waters saw the highest growth of 1.08% in patent filings in April and 1.37% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.08% and grants by 0.86%. GlobalData’s DataBook provides a comprehensive analysis of Waters’s patent filings and grants. Buy the databook here.
Waters has been focused on protecting inventions in United States(US) with 47 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 25% filings and 43% grants. The United States(US), European Patent Office(EPO), China(CN), and United Kingdom(GB) patent Office are among the top ten patent offices where Waters is filings its patents. Among the top granted patent authorities, Waters has 43% of its grants in United States(US), 22% in China(CN) and 21% in European Patent Office(EPO).
Thermo Fisher Scientific and Danaher could be the strongest competitors for Waters
Patents related to industrial automation and electronic medical record (emr) systems lead Waters's portfolio
Waters has the highest number of patents in industrial automation followed by, electronic medical record (emr) systems and healthtech. For industrial automation, nearly 19% of patents were filed and 55% of patents were granted in Q2 2024.
Petrochemicals related patents lead Waters portfolio followed by diagnostic imaging, and general surgery devices
Waters has highest number of patents in petrochemicals followed by diagnostic imaging, general surgery devices, healthcare it, and electronic document mgmt. For petrochemicals, nearly 6% of patents were filed and 10% of patents were granted in Q2 2024.
For comprehensive analysis of Waters's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.